Talis Biomedical Corporation (TLIS) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Talis Biomedical Corporat...

    OTC: TLIS · Real-Time Price · USD
    1.06
    -0.54 (-33.75%)
    At close: Apr 04, 2025, 9:37 AM

    Talis Biomedical Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Revenue
    		 412K 3.65M n/a
    Cost of Revenue
    		 41K 8.39M 2.62M
    Gross Profit
    		 371K -4.74M -2.62M
    Operating Income
    		 -66.81M -115.14M -191.82M
    Interest Income
    		 n/a n/a n/a
    Pretax Income
    		 -62.01M -113.01M -192.04M
    Net Income
    		 -62.01M -110.89M -190.46M
    Selling & General & Admin
    		 28.21M 40.73M 42.42M
    Research & Development
    		 40.69M 70.83M 157.59M
    Other Expenses
    		 -1.72M -1.16M -8.19M
    Operating Expenses
    		 67.19M 110.4M 191.82M
    Interest Expense
    		 n/a n/a n/a
    Selling & Marketing Expenses
    		 n/a n/a n/a
    Cost & Expenses
    		 67.23M 118.79M 191.82M
    Income Tax Expense
    		 n/a -2.13M -1.58M
    Shares Outstanding (Basic)
    		 1.82M 1.78M 1.51M
    Shares Outstanding (Diluted)
    		 1.82M 1.78M 1.51M
    EPS (Basic)
    		 -34.12 -62.45 -126.13
    EPS (Diluted)
    		 -34.12 -62.45 -126.13
    EBITDA
    		 -66.05M -106.31M -191.82M
    EBIT
    		 -66.81M -115.14M n/a
    Depreciation & Amortization
    		 770K 11.6M 2.62M

    Add to Watchlist